Beth Wittmer, RN, OCN: How Nurses Are Preparing for Anticancer Biosimilars

Beth Wittmer, RN, OCN, senior manager of care management at Florida Cancer Specialists, addresses how nurses are being educated about biosimilars. 
December 21, 2018




Transcript:

What are practices doing to prepare for the arrival of anticancer biosimilars, and how are nurses in particular being educated?

Well from our practice, we have a very large pharmacy, our own in-house pharmacy Rx to Go. They are preparing by meeting with the pharmaceutical companies and trying to find the best options payable as well as delivering the drug.

Then we work with the pharmacists there who give us education. For our care management department, we rolled that out in webinars to our nurses so that they’re well aware of the side effects and how to manage the patient.
 

x-button

Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2019 Intellisphere, LLC. All Rights Reserved.